NevenaDamjanovMD
Oncology • Philadelphia, PAGastrointestinal Cancer, Hematologic Oncology, Hospice & Palliative
Professor, Medicine, Perelman School of Medicine
Dr. Damjanov is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
51 N. 39th Street
220 Medical Office Building
Philadelphia, PA 19104Phone+1 215-662-9801Fax+1 215-243-3249
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1992 - 1996
Penn State Milton S Hershey Medical CenterResidency, Internal Medicine, 1989 - 1992
Drexel University College of MedicineClass of 1989
Certifications & Licensure
PA State Medical License 1990 - 2024
OH State Medical License 1996 - 2007- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 258 citationsDerazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinomaVincenzo Mazzaferro, Bassel F. El-Rayes, Michele Droz dit Busset, Christian Cotsoglou, William P. Harris
British Journal of Cancer. 2019-01-01 - 52 citationsA randomized dose‐response trial of aerobic exercise and health‐related quality of life in colon cancer survivorsJustin C. Brown, Nevena Damjanov, Kerry S. Courneya, Andrea B. Troxel, Babette S. Zemel
Psycho-Oncology. 2018-04-01 - 28 citationsEffects of exercise on circulating tumor cells among patients with resected stage I-III colon cancerJustin C. Brown, Andrew D. Rhim, Sara L. Manning, Luke Brennan, Alexandra I. Mansour
Plos One. 2018-10-17
Journal Articles
- Cisplatin Versus Cetuximab with Definitive Concurrent Radiotherapy for Head and Neck Squamous Cell Carcinoma: An Analysis of Veterans Health Affairs DataRavi Vinnakota, Keith Sigel, Joshua M Bauml, Roger B Cohen, Nevena Damjanov, Corey J Langer, Ronac Mamtani, Charu Aggarwal, Christina Knepley, Juan Wisnivesky, Cancer
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
